Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Two Firms Join to Develop Quick Flu Test

By Labmedica staff writers
Posted on 26 Jan 2006
A fast, lab-on-a-chip diagnostic test that will enable doctors to quickly detect strains of avian flue and other influenza viruses is being developed by STMicroelectronics (Geneva, Switzerland) and Veredus Laboratories (Singapore).

Using the In-Check platform of ST, Veredus is working on an application to specifically identify whether a patient is infected with the avian flu virus H5N1 or a subtype of influenza A or B in a single test, instead of requiring many tests. More...
The companies hope to have the test available for the next flu season in the fall of 2006. The In-Check platform is a complete laboratory-on-a-chip. It allows users to accurately and reliably perform the processing and analysis of a minute sample on a single disposable chip, and also reduces the risk of cross-contamination. The results are detected by a portable reader using optical signal acquisition and processed by ST's bioinformatics software.

"The World Health Organization recently identified rapid detection as the first requirement in fighting avian flu, and ST's leading-edge semiconductor expertise--combined with Veredus' expertise in avian flu detection--will enable new possibilities for effective timely detection and treatment so that early containment of the infection will be possible,” said Anton Hofmeister, group vice-president and general manager for ST's microfluidic division.

"We are actively developing chips to detect dengue fever, malaria, West Nile virus, yellow fever, typhoid fever, Japanese encephalitis, and other diseases and anticipate that our products will greatly improve treatment choices,” added Dr. Rosemary Tan, CEO of Veredus.




Related Links:
STMicroelectronics
Veredus Laboratories

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.